NewsRx

Search our medical news database

Illicit Drugs

Feds say "club drug"-related visits to ERs show some sharp declines

Published in Medical Letter on the CDC and FDA, September 5th, 2004

Emergency room visits related to "club drugs" - GHB, Ketamine, LSD, and Ecstasy - remained stable or headed downward in 2002, according to a new report for the Substance Abuse and Mental Health Services Administration (SAMHSA).

The report, "Club Drugs, 2002 Update," shows emergency room visits associated with GHB declined by one-third between 2000 and 2002, visits involving LSD declined rapidly between 1999 and 2002, visits involving Ecstasy remained at 2001 levels, and Ketamine-related visits remained at the low levels seen since 1998.

The report is based on SAMHSA's Drug Abuse Warning Network (DAWN) that collects data on drug abuse-related visits...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook